Antithrombotics in atrial fibrillation and coronary disease.

about

Clinical characteristics and one year outcomes in Chinese atrial fibrillation patients with stable coronary artery disease: a population-based study.Long-term prognosis in patients continuing taking antithrombotics after peptic ulcer bleeding.

P2860

Q37345221-D9A6B5C9-CFDE-451A-943C-845E88ECA401 Q37625235-2625F724-6471-402E-9853-B228A6D6025A

P2860

Antithrombotics in atrial fibrillation and coronary disease.

Item

http://www.wikidata.org/entity/Q38232135

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Antithrombotics in atrial fibrillation and coronary disease.

@en

type

Item

label

Antithrombotics in atrial fibrillation and coronary disease.

@en

prefLabel

Antithrombotics in atrial fibrillation and coronary disease.

@en

P1476

Antithrombotics in atrial fibrillation and coronary disease.

@en

P2093

Abraham G Kocheril

http://www.w3.org/2001/XMLSchema#string

Harsh Agrawal

http://www.w3.org/2001/XMLSchema#string

Kul Aggarwal

http://www.w3.org/2001/XMLSchema#string

Mayank Mittal

http://www.w3.org/2001/XMLSchema#string

Mohit K Turagam

http://www.w3.org/2001/XMLSchema#string

Poonam Velagapudi

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome

Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Associat

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Warfarin, aspirin, or both after myocardial infarction

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials

P304

977-986

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14779072.2014.937427

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25046150

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation

Antithrombotics in atrial fibrillation and coronary disease.

about

P2860

P2860

Antithrombotics in atrial fibrillation and coronary disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921